Paper Details 
Original Abstract of the Article :
Traumatic brain injury (TBI) has been regarded as one of the leading cause of injury-related death and disability. White matter injury after TBI is characterized by axon damage and demyelination, resulting in neural network impairment and neurological deficit. Brain-derived neurotrophic factor (BDNF...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.expneurol.2020.113462

データ提供:米国国立医学図書館(NLM)

Bexarotene: A New Path to Axon Regeneration After Traumatic Brain Injury

Traumatic brain injury (TBI) is a devastating condition that leaves many individuals with long-term disabilities. This study explores the potential of bexarotene, an agonist of retinoid X receptor (RXR), to promote axon regeneration after TBI. The researchers investigated the effects of bexarotene on brain-derived neurotrophic factor (BDNF) expression, microglia/macrophage activation, and axon sprouting in mice subjected to controlled cortical impact (CCI).

Bexarotene: A Bridge Across the Gap

The study found that bexarotene promoted axon regeneration after TBI, as evidenced by increased expression of growth-associated protein 43 (GAP43) and myelin basic protein (MBP), as well as increased biotinylated dextran amine (BDA)-positive axon sprouting. Bexarotene also increased microglia/macrophage-specific BDNF expression, shifted microglia/macrophages towards an anti-inflammatory state, and reduced pro-inflammatory cytokine secretion. These effects were partially abolished by the PPARγ antagonist T0070907.

A Potential for New Therapies

The study's findings suggest that bexarotene may offer a promising therapeutic strategy for promoting axon regeneration after TBI. The research provides valuable insights into the potential of bexarotene to enhance neurological recovery and improve functional outcomes in patients with TBI.

Dr.Camel's Conclusion

This study unveils the potential of bexarotene to promote axon regeneration after TBI. The findings suggest that bexarotene, by modulating BDNF expression and microglia/macrophage activation, can enhance neurological recovery and improve functional outcomes in patients with TBI. This research opens up a new path for exploring innovative therapies for TBI.

Date :
  1. Date Completed 2021-03-10
  2. Date Revised 2021-03-10
Further Info :

Pubmed ID

32916173

DOI: Digital Object Identifier

10.1016/j.expneurol.2020.113462

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.